Your trusted cell therapy CDMO for advanced manufacturing solutions

Cellipont Bioservices: a premier cell therapy CDMO committed to exceeding client expectations and advancing patient care.

Learn more today

Cellipont Bioservices Headquarters
Optimized Cell Therapy Production

Purpose-Built cGMP Manufacturing Facility

Our brand-new cGMP manufacturing facility in The Woodlands, Texas, marks a pivotal achievement in Cellipont’s dedication to advancing cell therapy development and manufacturing for patients around the globe.

Explore Our Facility

Our Services

Robust Tailored Offerings

With a team of industry-leading experts, we possess unmatched technical understanding of the complexities involved in the development and manufacturing of CAR-T. From process development to commercial manufacturing, our deep expertise allows us to offer tailored solutions that meet your unique project requirements.

Explore Services CAR-T Services

Biotech researchers collaborating in a GMP laboratory, reviewing cell therapy data and using high-precision lab equipment.
Scientists performing cell therapy research in a GMP-compliant biotechnology lab using pipettes and laboratory equipment.
Our Capabilities

Unlocking Potential Worldwide

At Cellipont Bioservices, we're dedicated to empowering our clients to bring life-changing medicines to patients worldwide. With our best-in-class cell therapy development, analytical, and manufacturing capabilities, we're your trusted partner in turning innovative ideas into impactful realities.

View Our Capabilities Clinical Manufacturing

Latest News

Kincell Bio and Cellipont Bioservices Merge to Form Kincellis Advanced Therapies. Combination creates a scaled U.S. advanced therapies CDMO with broader technical expertise and capabilities from early development through commercial supply.

  RESEARCH TRIANGLE PARK, NC and THE WOODLANDS, TX —  Sept. 17, 2026— Kincell Bio and Cellipont Bioservices today announced the completion of their merger...

Read More View Newsroom

Press Release

Cellipont Bioservices and Xiogenix Publish New White Paper on Automated Fill-Finish for Scalable Cell Therapy Manufacturing

READ MORE »

Press Release

Cellipont Bioservices’ Texas Facility Has Supported Six Client Projects Expected to Reach IND Submission in 2026

READ MORE »